NCT03103451View on ClinicalTrials.gov

First-in-human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-121 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Healthy
Interventions
DRUG

BCD-121

OTHER

Placebo

Sponsors

Lead Sponsor

Biocad
All Listed Sponsors
lead

Biocad

INDUSTRY

NCT03103451 - First-in-human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-121 in Healthy Subjects | Biotech Hunter | Biotech Hunter